1.Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells.
Ji Sung KIM ; Yong Guk KIM ; Minji PYO ; Hong Kyung LEE ; Jin Tae HONG ; Youngsoo KIM ; Sang Bae HAN
Immune Network 2015;15(2):58-65
Melanoma is the most aggressive skin cancer and its incidence is gradually increasing worldwide. Patients with metastatic melanoma have a very poor prognosis (estimated 5-year survival rate of <16%). In the last few years, several drugs have been approved for malignant melanoma, such as tyrosine kinase inhibitors and immune checkpoint blockades. Although new therapeutic agents have improved progression-free and overall survival, their use is limited by drug resistance and drug-related toxicity. At the same time, adoptive cell therapy of metastatic melanoma with tumor-infiltrating lymphocytes has shown promising results in preclinical and clinical studies. In this review, we summarize the currently available drugs for treatment of malignant melanoma. In addition, we suggest cytokine-induced killer (CIK) cells as another candidate approach for adoptive cell therapy of melanoma. Our preclinical study and several previous studies have shown that CIK cells have potent anti-tumor activity against melanomas in vitro and in an in vivo human tumor xenograft model without any toxicity.
Cell- and Tissue-Based Therapy*
;
Cytokine-Induced Killer Cells*
;
Drug Resistance
;
Heterografts
;
Humans
;
Incidence
;
Lymphocytes, Tumor-Infiltrating
;
Melanoma*
;
Prognosis
;
Protein-Tyrosine Kinases
;
Skin Neoplasms
;
Survival Rate
2.Prevalence of DSM-IV Major Psychiatric Disorders among North Korean Defectors in South Korea
Kyoung Eun LEE ; Carolyn Seungyoun MOON ; Ji Hyun AN ; Hyo Chul LEE ; Da Eun KIM ; Subin PARK ; Minji LEE ; Hye In CHANG ; Jin Pyo HONG
Psychiatry Investigation 2020;17(6):541-546
Objective:
The aim of this study was to estimate the prevalence of major psychiatric disorders among North Korean defectors (NKD) settled in South Korea.
Methods:
The study population consisted of 294 North Korean defectors, aged 18 to 64 years settled in South Korea for 3 years or less. Between June 1, 2016 and October 31, 2016, face-to-face interviews were conducted using the North Korean version of the WHO-Composite International Diagnostic Interview (NK-CIDI) to diagnose DSM-IV psychiatric disorders.
Results:
The lifetime prevalence of any DSM-IV psychiatric disorders was 62.2% in NKD and 25.0% in the general Korean population. The prevalence of specific disorders in NKD and general Korean population was as follows: 22.3% and 4.9% for major depressive disorder (MDD), 12.2% and 1.4% for post-traumatic stress disorder (PTSD), 18.0% and 4.8% for nicotine dependence, and 14.5% and 11.2% for alcohol abuse. The incidence of every single psychiatric disorder varied in each country. For instance, the generalized anxiety disorder, specific phobia, and alcohol use disorder occurred more frequently in North Korea whereas PTSD was more prevalent in other countries.
Conclusion
The prevalence of psychiatric disorders among NKD was quite higher than in the general population of South Korea.